Showing results (351-360 of 398) with videos related to

Sort By:
Pageof 40
Asia-Pacific Journal of Clinical Oncology|October 14, 2020
Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 studyTie Zhou, Fangjian Zhou, Jianming Guo, et al.
Cancers|February 16, 2019
SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric CancerHéctor G van den Boorn, Ameen Abu-Hanna, Emil Ter Veer, et al.
The Lancet. Oncology|December 15, 2023
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 studyEnrique Grande, José Á Arranz, Maria De Santis, et al.
Therapeutic Advances in Medical Oncology|September 23, 2021
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, et al.
The Lancet. Oncology|December 15, 2023
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 studyAristotelis Bamias, Ian D Davis, Matthew D Galsky, et al.
Oncotarget|May 26, 2016
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosisJi Yun Lee, InKyoung Lee, Won Jin Chang, et al.
Oncology|August 22, 2018
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life NomogramFilippo Pietrantonio, Francesco Barretta, Valentina Fanotto, et al.
Future Oncology (London, England)|April 13, 2022
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancerThomas Powles, Se Hoon Park, Eric Voog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 StudyEmmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
Cancer Medicine|February 21, 2025
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective ExperienceMimma Rizzo, Franco Morelli, Yüksel Ürün, et al.
Pageof 40